Turnstone Biologics Corp. Common Stock (TSBX) — Cash Flow Quality Index
Turnstone Biologics Corp. Common Stock (TSBX) has a Cash Flow Quality Index of -252.50x as of March 2023. Operating cash flow of $-17.17 Million is below net income of $68.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Turnstone Biologics Corp. Common Stock cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Turnstone Biologics Corp. Common Stock Cash Flow Quality Index (2021–2021)
Historical Cash Flow Quality Index for Turnstone Biologics Corp. Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Turnstone Biologics Corp. Common Stock to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Quality Index for Turnstone Biologics Corp. Common Stock (2021–2021)
Year-by-year earnings quality comparison for Turnstone Biologics Corp. Common Stock. For live market cap and the full company financial profile, see Turnstone Biologics Corp. Common Stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | -1.37x | $-45.63 Million | $33.27 Million | — |